Track INCR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$50.55M
Enterprise Value$88.88M
Revenue (TTM)$81.81M
Net Income (TTM)-$11.68M
Free Cash Flow (TTM)-$11.44M
Financial Health
Cash$15.31M
Net Debt$38.33M
Debt Ratio0.24
Debt to Equity0.41
Interest Coverage0.95
Valuation (TTM)
Price to Sales0.62
Price to Earnings-4.33
EV to EBITDA-10.58
Price to Book0.39
Price to Free Cash Flow-4.42
Margins (TTM)
Gross Profit Margin24.55%
EBITDA Margin-10.26%
Operating Income Margin-11.18%
Net Income Margin-14.27%
Free Cash Flow Margin-13.99%
Returns (5Y Avg)
Return on Invested Capital-1.23%
Return on Assets-1.03%
Return on Equity-5.94%
Return on Total Capital-1.23%
Return on Capital Employed-1.00%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date-
5-Year Dividend CAGR-
CAGR (5Y)
Revenue32.96%
Diluted EPS12.64%
Total Debt119.92%
Capital Expenditures-29.82%
Free Cash Flow7.74%
CAGR (3Y)
Revenue-11.41%
Diluted EPS-19.54%
Total Debt-11.01%
Capital Expenditures-43.56%
Free Cash Flow-6.30%
CAGR (1Y)
Revenue13.13%
Diluted EPS78.44%
Total Debt-13.11%
Capital Expenditures-18.90%
Free Cash Flow1000.00%
$0.91-$0.00|-0.31%
52W High$1.77
52W Low$0.68
50D SMA$0.96
200D SMA$1.05
Volume14.52K
InterCure Ltd.
85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670
IPO
2014
Employees
285
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Insider Transactions
Quarterly buy vs. sell activity
No insider transactions data available for this period
Analyst Ratings
No coverage data
No analyst ratings data available